University of Tasmania
Browse
Emmett_ISNCongress poster_.pdf (532.17 kB)

Effect of haemodialysis session frequency and duration on survival in Australian end-stage kidney disease patients: a retrospective cohort study

Download (532.17 kB)
conference contribution
posted on 2023-05-24, 18:36 authored by Emmett, C, Pamela MacintyrePamela Macintyre, Alex KitsosAlex Kitsos, Charlotte McKercher, Matthew JoseMatthew Jose, Silvana BettiolSilvana Bettiol

Introduction: End-stage kidney disease patients have increased mortality compared to the general population. Haemodialysis (HD) of more frequent and of longer duration has been proposed to improve survival but it remains unclear if this is attributed to increased frequency, duration, or both. We aimed to examine the independent effects of session frequency and duration on mortality in incident HD patients.

Methods: A retrospective cohort study was performed using data from the Australian and New Zealand Dialysis and Transplant Registry examining non-Indigenous patients aged ≥18 years who initiated HD of ≥3 sessions/week in Australia from 2001 to 2015. Initial dialysis prescription was categorized as session duration >5 h/session compared to ≤5 h/session and session frequency as >3 sessions/week compared to 3 sessions/week. Survival analysis was performed using Cox regression analysis, with multivariable analysis controlling for available covariates.

Results: We examined 16 944 patients of whom 757 (4.5%) received >3 sessions/week and 518 (3.1%) received >5 h/session. After controlling for frequency, patients initiated on HD sessions >5 h had a significantly reduced risk of mortality compared with patients with HD session ≤5 h (adjusted hazard ratio (HR) = 0.57; 95% confidence interval (CI) = 0.44-0.74). In contrast, patients initiated on >3 sessions/week of HD had a similar risk of death when compared with patients on 3 sessions/week of HD (adjusted HR = 0.97; 95% CI = 0.84-1.13), after controlling for duration. Limitations include potential residual confounding and changes in exposure over time.

Conclusions: Longer duration rather than increased frequency of treatment appears to reduce mortality in HD patients. This has implications for management and requires further study.

History

Publication title

ISN World Congress of Nephrology 2019

Volume

4 (7)

Pagination

S12

ISSN

2468-0249

Department/School

Tasmanian School of Medicine

Publisher

Elsvier Inc.

Place of publication

Kidney International Reports

Event title

ISN World Congress of Nephrology 2019

Event Venue

Melbourne, Australia

Date of Event (Start Date)

2019-04-12

Date of Event (End Date)

2019-04-15

Repository Status

  • Open

Socio-economic Objectives

Diagnosis of human diseases and conditions; Public health (excl. specific population health) not elsewhere classified; Expanding knowledge in the health sciences